Clever Leaves Holdings Inc Ordinary Shares CLVR
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if CLVR is a good fit for your portfolio.
News
Trading Information
- Previous Close Price
- $4.11
- Day Range
- $1.52–1.91
- 52-Week Range
- $1.52–9.60
- Bid/Ask
- $1.56 / $1.66
- Market Cap
- $2.84 Mil
- Volume/Avg
- 769,704 / 35,026
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- 0.37
- Dividend Yield (Trailing)
- —
- Dividend Yield (Forward)
- —
- Total Yield
- —
Company Profile
Clever Leaves Holdings Inc is a producer of pharmaceutical and consumer cannabis brands. The company operates and has investments in Canada, Colombia, Germany, Portugal, and the United States. The company operates in two reportable segments namelyThe Cannabinoid operating segment which is comprised of the company’s cultivation, extraction, and commercialization of cannabinoid products; and Non-Cannabinoid operating segment is engaged in the business of formulating, manufacturing, marketing, selling, distributing, and otherwise commercializing nutraceutical and other natural remedies, wellness products, detoxification products, and nutritional and dietary supplements.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Stock Style Box
- Small Value
- Total Number of Employees
- 296
- Website
- https://www.cleverleaves.com
Valuation
|
Metric
|
CLVR
|
|---|---|
Price/Earnings (Normalized) | — |
Price/Book Value | 0.29 |
Price/Sales | 0.37 |
Price/Cash Flow | — |
Price/Earnings
No chart available
Financial Strength
|
Metric
|
CLVR
|
|---|---|
Quick Ratio | 1.53 |
Current Ratio | 2.40 |
Interest Coverage | −427.89 |
Quick Ratio
CLVR
Profitability
|
Metric
|
CLVR
|
|---|---|
Return on Assets (Normalized) | −43.50% |
Return on Equity (Normalized) | −55.40% |
Return on Invested Capital (Normalized) | −51.18% |
Return on Assets
CLVR
Drug Manufacturers - Specialty & Generic Industry Comparables
|
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|
ZTS
| Zoetis Inc Class A | Xvpzcjhsq | Wjb | $72.4 Bil | |
MKKGY
| Merck KGaA ADR | Dcnpnrqvfc | Jbpzwhs | $70.8 Bil | |
HLN
| Haleon PLC ADR | Nfkkzrkcs | Xmb | $38.2 Bil | |
VTRS
| Viatris Inc | Yfgphspb | Cztwf | $13.8 Bil | |
RDY
| Dr Reddy's Laboratories Ltd ADR | Kdhgqlfd | Fdcm | $12.5 Bil | |
CTLT
| Catalent Inc | Qzspcltf | Tzrcv | $10.1 Bil | |
PRGO
| Perrigo Co PLC | Bjlbbdc | Czs | $4.3 Bil | |
CURLF
| Curaleaf Holdings Inc | Tjthpqx | Rkkmj | $3.7 Bil | |
PBH
| Prestige Consumer Healthcare Inc | Xvrjcnx | Dqtfvw | $3.5 Bil | |
GTBIF
| Green Thumb Industries Inc | Lqwplngcs | Zzjx | $2.9 Bil |